双管硬通道微创钻孔治疗慢性硬膜下血肿的疗效分析  

Efficacy analysis of double-barreled hard channel minimally invasive drilling in treatment of chronic subdural hematoma

作　　者：余永强[1] 叶文珊[1] 梁全[1] 刘洋[1] 谭杨劲 

机构地区：[1]广东省惠州市第三人民医院神经外科,广东惠州516000

出　　处：《中国现代医生》2014年第17期158-160,共3页China Modern Doctor

基　　金：广东省惠州市科技计划项目(20120802)

摘　　要：目的探讨双管硬通道微创钻孔(DTMTHPD)治疗慢性硬膜下血肿(CSDH)的疗效。方法 100例CSDH患者随机分为A组(n=50)和B组(n=50),分别采用传统钻孔冲洗引流术和双管硬通道微创钻孔冲洗引流术进行治疗,对比两组的治疗效果、并发症和患者满意度。结果 B组的疗效显著和好转例数均较A组增多且治疗无效的患者显著减少,总有效率96.0%,显著高于A组(P<0.05)。B组患者血肿复发、继发颅内血肿、颅内积气等并发症的发生例数均较A组显著减少(P<0.01)。B组患者总体满意度(84%)高于A组(70%),差异有统计学意义(χ2=4.57,P<0.05)。结论 DTMTHPD冲洗引流术治疗CSDH治愈率高,并发症少,疗效优于传统钻孔引流术。Objective To investigate the efficacy of double-barreled hard channel minimally invasive drilling （DTMTHPD） in the treatment of chronic subdural hematoma（CSDH）. Methods One hundred patients with CSDH were randomly divided into group A （n=50） and group B （n=50）, and group A received the traditional drilling irrigation and drainage treatment and group B received the double-barreled hard channel minimally invasive drilling irrigation and drainage treatment respectively. The treatment effects, complications and patient satisfaction of the two groups were compared. Results The numbers of patients with remarkable efficacy and improvement of group B both increased compared with those of group A and the number of ineffective patients reduced significantly. The total effective rate of group B was 96.0%, which was significantly higher than that of group A （P〈0.05）. The numbers of cases of hematoma recurrence, secondary intracranial hematoma, intracranial pneumatosis and other complications of group B all reduced significantly compared with those of group A （P〈0.01）. The overall satisfaction of group B （84%） was higher than that （70%） of group A, with statistically significant difference （x2=4.57,P〈0.05）. Conclusion DTMTHPD irrigation and drainage has higher cure rate, less complications and better efficacy than the traditional drilling drainage in the treatment of CSDH.

关 键 词：慢性硬膜下血肿 双管硬通道 微创钻孔 并发症 

分 类 号：R651[医药卫生—外科学]